GLP-1 Agonists Like Semaglutide Show Promise in Reducing Alcohol Use Disorder, Study Finds Feb 20, 2025 2 min read Updated: Nov 6, 2025 Recent research suggests that semaglutide, a medication primarily used for type 2 diabetes and weight management, may also help reduce alcohol consumption
Best, S
Millichap JG, Yee MM
Please consult our Cape Fear Physical Medicine and Rehab healthcare provider to discuss your individual health profile, set achievable weight-loss targets, and receive ongoing support and guidance throughout your treatment experience with weight loss injections
Prescribing trends are being driven by growing evidence that suggest GLP-1s provide benefits well beyond glucose control and weight management, spanning therapy areas from cardiovascular risk reduction to potential applications in neurological conditions such as Parkinsons disease 2
Figure 2: The pineal glands anatomical position within the neuroendocrine hub explains its outsized influence on circadian, immune, and hormonal systems, making Epitalons tissue-specific action particularly significant
